PMC:7558914 / 24960-25084
Annnotations
LitCovid_Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T37 | 28-35 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T38 | 28-35 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 598 | 88-96 | Species | denotes | patients | Tax:9606 |
| 606 | 28-35 | Chemical | denotes | heparin | MESH:D006493 |
| 622 | 113-123 | Disease | denotes | thrombosis | MESH:D013927 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T159 | 0-124 | Sentence | denotes | An increase in prophylactic heparin doses was recommended in 53.3% of the protocols for patients at high risk of thrombosis. |